#TheMarketsTrustIsrael: Israeli MedTech Start-up raised $20 Million. Funding led by INTEL Capital

The daily news refuting the left lie spreaded by left leaning media that the markets allegedly do not trust Israel and Israeli companies. The opposite is true.

It is irresponsible behavior towards Israel and its people, especially by left-wing Israeli politicians and media, to spread this incitement and untruths about Israel. The truth is, that investors and global companies trust Israel and Israeli companies. Today: The MedTech platform ‘MDH Health’

The medTech platform was established 2019 in Telv Aviv by Avishai Ben-Tovim (CEO), Dr. Dorit Dil Nahalieli (CSO), and Yuval Kalev (CTO).

Current medication management solutions are largely alert-based, focusing on drug interactions and requiring laborious processes. Whereas, MDI Health’s AI medication management platform is autonomous and hyper-personalized.

It analyzes thousands of influencing factors to identify medication-related risks – and provides a recommendation to mitigate such risks – in a matter of minutes instead of hours, driving significant cost savings and improved health outcomes at scale.

MDI Health, an AI-powered platform that automates the optimization of personalized medication treatment, at scale, has raised $20 million in Series A funding led by Intel Capital with participation from Maverick Ventures Israel and existing investors Hanaco Ventures, Welltech Ventures, Arc Impact, Basad Ventures, Fresh.Fund, Jumpspeed Ventures and former SVP of Optum Richard Montwill.